GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth
ORIGINAL SOURCE →via Seeking Alpha
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · conflict
- [CONFLICT] Intermodal Asia
- [CONFLICT] Securing the Untrusted Agentic Development Layer
- [CONFLICT] Sudan blames UAE, Ethiopia for drone attack in capital's airport
- [CONFLICT] US sinks Iranian small boats, shoots down missiles, drones as reopening of Strait underway
- [CONFLICT] Soldier assaults TheCable journalist in Lagos traffic altercation
- [CONFLICT] Experts promote rabbit value chain investment